These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15064038)

  • 1. WHO, the Global Fund, and medical malpractice in malaria treatment.
    White N; Nosten F; Björkman A; Marsh K; Snow RW
    Lancet; 2004 Apr; 363(9415):1160. PubMed ID: 15064038
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO, the Global Fund, and medical malpractice in malaria treatment.
    Watkins B; Kokwaro G; Galinski M; Mutabingwa TK; Trape JF
    Lancet; 2004 Apr; 363(9415):1161-2. PubMed ID: 15064042
    [No Abstract]   [Full Text] [Related]  

  • 3. WHO, the Global Fund, and medical malpractice in malaria treatment.
    Adelman CC; Norris J
    Lancet; 2004 Apr; 363(9415):1161. PubMed ID: 15064041
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO, the Global Fund, and medical malpractice in malaria treatment.
    de Vries PJ; Kager PA; Borgdorff MW
    Lancet; 2004 Apr; 363(9415):1161. PubMed ID: 15064040
    [No Abstract]   [Full Text] [Related]  

  • 5. WHO, the Global Fund, and medical malpractice in malaria treatment.
    Attaran A; Barnes KI; Curtis C; d'Alessandro U; Fanello CI; Galinski MR; Kokwaro G; Looareesuwan S; Makanga M; Mutabingwa TK; Talisuna A; Trape JF; Watkins WM
    Lancet; 2004 Jan; 363(9404):237-40. PubMed ID: 14738799
    [No Abstract]   [Full Text] [Related]  

  • 6. The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment.
    Attaran A; Barnes KI; Bate R; Binka F; d'Alessandro U; Fanello CI; Garrett L; Mutabingwa TK; Roberts D; Sibley CH; Talisuna A; Van Geertruyden JP; Watkins WM
    Lancet; 2006 Jul; 368(9531):247-52. PubMed ID: 16844495
    [No Abstract]   [Full Text] [Related]  

  • 7. The Booster Program for Malaria Control: putting knowledge and money to work.
    Sarbib JL; Nankani G; Patel P
    Lancet; 2006 Jul; 368(9531):253-7. PubMed ID: 16844496
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to accusations of medical malpractice by WHO and the Global Fund.
    Nafo-Traoré F
    Lancet; 2004 Jan; 363(9406):397. PubMed ID: 15070574
    [No Abstract]   [Full Text] [Related]  

  • 9. Why the world needs another malaria initiative.
    Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715
    [No Abstract]   [Full Text] [Related]  

  • 10. The Global Fund expands its role. Interview by the Bulletin.
    Kazatchkine M
    Bull World Health Organ; 2007 Oct; 85(10):742-3. PubMed ID: 18038053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Fund and effective malaria treatment.
    Lidén J; Nantulya VM
    Lancet; 2004 Apr; 363(9418):1396. PubMed ID: 15110502
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to accusations of medical malpractice by WHO and the Global Fund.
    Nantulya VM; Lidén J
    Lancet; 2004 Jan; 363(9406):397-8. PubMed ID: 15070573
    [No Abstract]   [Full Text] [Related]  

  • 13. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
    Laxminarayan R; Over M; Smith DL
    Health Aff (Millwood); 2006; 25(2):325-36. PubMed ID: 16522574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost is killing patients: subsidising effective antimalarials.
    Talisuna A; Grewal P; Rwakimari JB; Mukasa S; Jagoe G; Banerji J
    Lancet; 2009 Oct; 374(9697):1224-6. PubMed ID: 19819377
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
    Goodman CA; Coleman PG; Mills AJ
    Health Econ; 2001 Dec; 10(8):731-49. PubMed ID: 11747054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in malaria chemoprophylaxis prescription in South Africa 1994 to 2000.
    Leggat PA; Dürrheim DN; Blumberg L
    J Travel Med; 2002; 9(6):318-21. PubMed ID: 12962587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One more reason to fund the Global Fund.
    Sabot O; Hall S
    Lancet; 2012 Jan; 379(9813):e25-6. PubMed ID: 22100853
    [No Abstract]   [Full Text] [Related]  

  • 18. The Global Fund and a new modus operandi.
    Lancet; 2011 Dec; 378(9807):1896. PubMed ID: 22137831
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial resistance: time to repurpose the Global Fund.
    The Lancet
    Lancet; 2022 Jan; 399(10322):335. PubMed ID: 35065769
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
    Kovacs SD; Mills BM; Stergachis A
    Malar J; 2017 Jul; 16(1):282. PubMed ID: 28693488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.